)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals (CPRX) investor relations material
Catalyst Pharmaceuticals has been delisted
Catalyst Pharmaceuticals EGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.EGM 2026 summary8 Jul, 2026
Opening remarks and agenda
Meeting commenced with instructions for participation and a welcome from the board chair.
Agenda included voting on three specific proposals as outlined in the proxy statement.
Board and executive committee updates
Introductions of all board members and executive officers were made at the start of the meeting.
Corporate governance
The chairperson was authorized to preside and set meeting procedures per the company's bylaws.
The record date for voting was set as June 3, 2026, and all required notices and proxy materials were confirmed as mailed.
Inspector of Election was appointed and sworn in, with responsibilities for vote canvassing and reporting.
Quorum was confirmed with a majority of shares represented.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Catalyst Pharmaceuticals
- DMD therapies advance with novel delivery, regulatory support, and key data expected in Q1.CPRX
Citi's 2024 Global Healthcare Conference - Shareholders will vote on a merger with Angelini Pharma amid legal scrutiny and executive retention plans.CPRXProxy filing
- Shareholders to vote on $31.50/share cash merger with Angelini Pharma, board recommends approval.CPRXProxy filing
- Shareholders to vote on a $31.50/share cash merger with Angelini Pharma, unanimously backed by the board.CPRXProxy filing
- Merger with Angelini Pharma announced; Q1 2026 revenues up 28.2% to $149.4 million.CPRXProxy filing
- Strong growth in rare disease portfolio, robust cash, and strategic expansion plans for 2026.CPRXBarclays 28th Annual Global Healthcare Conference
- Q3 revenue up 25.3% year-over-year, with raised guidance and strong cash reserves.CPRXQ3 2024
- Q1 2025 revenue surged 43.6% to $141.4M, led by FIRDAPSE and AGAMREE growth.CPRXQ1 2025
- Record revenue and net income growth in 2024, with strong 2025 outlook and robust cash position.CPRXQ4 2024
Catalyst Pharmaceuticals
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Catalyst Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare neurological and neuromuscular diseases. The company's portfolio includes treatments designed to address conditions such as Lambert-Eaton Myasthenic Syndrome (LEMS) and other disorders that have limited treatment options. The company is headquartered in Coral Gables, Florida, and its shares are listed on the NASDAQ.